insights_auto
Why is SOBI up 2,39%?
Dive Deeperchevron_right
SOBI:STO
Swedish Orphan Biovitrum AB (publ)
437,40 SEK
arrow_upward
+2,39%(+10,20) 1D
14 қаз., 17:29:59 GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
427,40 SEK
High
438,00 SEK
Low
424,80 SEK
Mkt. cap
156,43 млрд
Avg. vol.
255,84 м.
Volume
360,38 м.
P/E ratio
116,82
52-wk high
487,00 SEK
52-wk low
293,60 SEK
EPS
3,74 SEK
Shares outstanding
357,64 млн
No. of employees
2 мың
Open
427,40 SEK
High
438,00 SEK
Low
424,80 SEK
Mkt. cap
156,43 млрд
Avg. vol.
255,84 м.
Volume
360,38 м.
P/E ratio
116,82
52-wk high
487,00 SEK
52-wk low
293,60 SEK
EPS
3,74 SEK
Shares outstanding
357,64 млн
No. of employees
2 мың
News stories
From web sources and news partners
Yahoo
·
1 сағат бұрын
Dow closes in the red after report finds inflation rose in September
Honolulu Star-Advertiser
·
20 минут бұрын
Nasdaq suffers biggest daily drop since July as inflation heats up
Simply Wall Street
·
1 сағат бұрын
Honeywell International (HON) Debuts Forge Cognition For Facility Operations
Bloomberg.com
·
2 сағат бұрын
S&P 500 Ends Longest Streak of Calm Since 2020 as AI Trade Sinks
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)